Which Is the Better Global ETF, Vanguard's VT or State Street's SPGM?

VT offers the lower cost option at a 0.06% expense ratio versus 0.09% for SPGM, while SPGM has the stronger recent performance with a 28.4% 1-year return versus 25.7% for VT and a higher 5-year growth of $1,000 ($1,690 vs. $1,647). VT is far more diversified with 9,773 holdings and much larger AUM of $95.3B versus SPGM's 2,924 holdings and $1.7B AUM. The piece is a comparative ETF analysis highlighting a tradeoff between cost and diversification versus recent performance and yield.

Analysis

This is not a broad “buy the cheaper ETF” story; it is a micro decision between two wrappers around the same underlying global beta. The more important second-order effect is that VT’s much larger asset base and deeper constituent set makes it the cleaner vehicle for long-horizon capital that cares about implementation quality, while SPGM’s sampling approach can create modest tracking error that sometimes flatters recent returns in strong mega-cap regimes. That means the performance gap is less likely to be persistent alpha and more likely a regime artifact tied to a narrow leadership cohort.

The real beneficiary set is the large-cap global growth complex, especially NVDA, AAPL, and MSFT, because both funds are effectively “hidden” buyers of the same index leaders. If global ETF flows keep favoring one-stop products, passive demand continues to compress dispersion at the top of the market cap stack while starving smaller ex-U.S. names of incremental capital. That can widen the valuation gap between index titans and the long tail, even when the fund-level choice appears neutral.

The contrarian read is that the higher-yield, higher-recent-return SPGM may be a crowded recency trade masquerading as a value proposition. If rates stabilize or fall, the market could rotate toward broader participation and smaller-cap / ex-U.S. exposure, which would favor VT’s deeper diversification and greater exposure to the parts of the world market that have lagged mega-cap U.S. tech. The underappreciated risk for both products is concentration: despite thousands of holdings, returns are still dominated by a handful of names, so any air-pocket in the top five holdings can overwhelm the “diversification” narrative over a 3-6 month horizon.

Key Decisions for Investors

• Prefer VT over SPGM for strategic core allocation over the next 12 months: lower fee, better liquidity, and less sampling risk. Use VT for new capital unless the mandate explicitly prioritizes short-term distribution yield.
• For investors already in SPGM, consider a gradual rotation into VT on any market pullback of 3-5% in global equities; the expected tracking benefit is modest, but implementation quality should compound over multi-year holding periods.
• Long NVDA / short broad global ETF basket via VT or SPGM on a 1-3 month horizon as a pair trade if you expect index concentration to keep amplifying mega-cap flow support. Risk: any sharp rotation away from AI leaders would compress the spread quickly.
• If rates begin to fall meaningfully, add exposure to non-U.S. and smaller-cap global equities rather than adding more mega-cap tech through either ETF. This is the cleaner way to express a breadth rebound than trying to pick the better wrapper.
• Use both ETFs as liquidity proxies for global risk appetite: a relative-strength breakout in SPGM vs VT would likely signal continued narrow leadership; a reversal favors broader participation and should prompt de-risking of concentrated growth exposure.